期刊文献+

血栓抽吸导管在ACS急诊PCI中的临床应用研究 被引量:3

Clinical Study on Application of Thrombus Aspiration Catheter in Primary PCI Treatment of Patients with Acute Coronary Syndrome
暂未订购
导出
摘要 目的探讨血栓抽吸导管治疗在ACS常规急诊PCI中的临床疗效。方法选择2010年1月-2011年5月我院住院行急诊经皮冠状动脉介入(PCI)治疗的93例急性ST段抬高型心肌梗死和高危、极高危非ST段抬高急性冠脉综合症(ACS)患者,随机分为联用ThrombusterⅡ血栓抽吸导管治疗为A组(51例),同期未应用血栓抽吸导管治疗为B组(42例)。比较两组患者术后心肌梗死溶栓(TIMI)血流、校正TIMI帧数(CTFC)、术后心肌呈色分级(BMG)、术后ST段抬高回落幅度及左心室射血分数(LVEF)、住院期间主要心血管不良事件(MACE)有无差异。结果 A组TIMI血流3级、CTFC、BMG、术后ST段抬高回落幅度及LVEF均优于B组,差异均有统计学意义(P<0.05)。两组患者院内MACE发生率比较,差异无统计学意义(P>0.05)。结论在ACS常规急诊PCI中联用ThrombusterⅡ血栓抽吸导管治疗可显著改善患者TIMI血流、心肌组织水平灌注及术后心功能,但住院期间MACE的发生率无差异。 Objective To evaluate the application of Thrombuster thrombus aspiration catheter in primary PCI treatment of patients with acute coronary syndrome.Methods 51 ACS patients were treated with primary PCI plus ThrombusterⅡ thrombus aspiration catheter(A group) and 42 ACS patients were treated only with routine primary PCI(Bgroup).The regression rate of TIMI,CTFC,BMG,ST segment,LVEF,incidence of no-reflow/slow-flow、mortality and MACE were followed up after PCI during hospitalization.Results The difference of TIMI、CTFC、BMG、ST segment、LVEF、incidence of no-reflow/slow-flow between the two groups was statistically significant(P〈0.05),mortality and incidence of MACE followed up after PCI during hospitalization didn't reduce.Conclusion Transcatheter aspiration of coronary thromus using ThrombusterⅡ thromus aspiration catheter followed by direct stenting is an effective method to decrease morbidity of no-reflow/slow-flow and improve heart function during emergency PCI in ACS patient.
出处 《血栓与止血学》 2011年第5期203-206,共4页 Chinese Journal of Thrombosis and Hemostasis
关键词 急性冠脉综合症 血栓抽吸导管 经皮冠状动脉介入 Acute coronary syndrome Thrombus aspiration catheter Percutaneous coronary intervention
  • 相关文献

参考文献2

二级参考文献4

共引文献580

同被引文献20

  • 1杨人强,程晓曙,吴清华,吴延庆,姜醒华,徐劲松,游志刚.选择性血栓抽吸导管的应用有利于急诊PCI术急性心肌梗死患者的预后[J].岭南心血管病杂志,2011,17(S1):47-47. 被引量:1
  • 2Eeckhout E,Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies[ J]. Eur Heart J,2001,22(9) :729-739.
  • 3Nakazawa G,Tanabe K,Onuma,et al.Efficacy of culprit plaque assessment by 64-slice multidetector computed tomography to predict transient no-reflow phenomenon during percutaneous coronary intervention[J].Am Heart J,2008,155(6):1150-1157.
  • 4Amano H,Wagatsuma K,Yamazaki J,et al.Virtual histology intravascular ultrasound analysis of attenuated plaque and ulcerated plaque detected by gray scale intravascular ultrasound and the relation between the plaque composition and slow flow/no reflow phenomenon during percutaneous coronary intervention[J].J Interv Cardiol,2013,26:(3)294-301.
  • 5Muller O,Trana C,Eeckhout E.Myocardial no-reflow treatment[J].Curr Vasc Pharmacol,2013,11(2):278-285.
  • 6Peng Y,Jiahui L,Aili L,et al.Garlicin attenuates reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction[J].Artif Cell Blood Sub,2012,40(4):285-289.
  • 7Pierrakos C N,Bonios M J,Drakos S G,et al.Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon:an experimental study[J].Artif Organs,2011,35 (9):867-874.
  • 8Huang D,Qian J,Ge L,et al.Restoration of coronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)[J].Am Heart J,2012,164 (3):394-401.
  • 9Ikenaga H,Ishihara M,Inoue I,et al.Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J].J Cariol,2013,62(2):71-76.
  • 10Bozbeyoglu E,Satilmis S,Aksu H.Impact of clopidogrel resistance on ST-segment resolution and no-reflow in acute myocardial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention[J].Coronary Artery Dis,2012,23(8):523-527.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部